Bangladesh signs Vaccine Agreement with Serum Institute of India

Dhaka: The government of Bangladesh on Sunday signed an agreement with the Serum Institute of India (SII) for procurement of 3 crore doses of the Oxford/ Astrazeneca vaccine. The vaccine will be delivered in six installments of 50 lakh doses each.

Health Minister Zahed Maleq told the media after the signing of the agreement that the vaccine has proved safe during trials in different countries and it is suitable for Bangladesh. He said the government is also in talks with other countries to procure more doses of the COVID-19 vaccine.

Earlier, on November 15, a tripartite MoU was signed between SII, Bangladesh pharmaceutical company Beximco Pharmaceuticals Ltd (BPL) and the government of Bangladesh for the procurement of the Oxford/Astrazeneca COVID-19 vaccine.

In the meanwhile, Bangladesh reported 32 more deaths due to Coronavirus on Sunday taking the death toll to 7,052. According to the latest figures released by the Directorate General of Health Services (DGHS), 1,355 new cases and 3,393 recoveries were also reported over the last 24 hours. Total number of people infected by Coronavirus in Bangladesh now stands at 4.9 lakh. Recovery rate in the country is 85.80 per cent.

LEAVE A REPLY

Please enter your comment!
Please enter your name here